Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial ...

However, analysts at Roth MKM are keeping the firm's price target at $55 while also keeping a buy rating on the shares.

Greetings, and welcome to the Omega Healthcare Investors first quarter 2024 earnings conference Call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn ...

On delivered revenue growth of 31% on a constant-currency basis in the fourth quarter. The company is scheduled to release first-quarter 2024 results on Tuesday, May 14. For the full year, management ...